Lidocaine Knee Pain Relief Patch
NDC Package 87518-189-25

11-digit billing NDC: 87518018925
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Lidocaine Knee Pain Relief Patch (lidocaine) patches is adults and Children above 12 years old:· Clean and dry the affected area.· Tear off the protective film and apply the exposed part of the patch to the affected area.· Carefully remove remaining film while pressing the patch firmly on the skin.· Apply 1 patch at a time to affected area, not more than 3 to 4 times daily.· Remove patch from the skin after at most 8-hour applicationChildren under age of 12:Consult a doctor. This formulation utilizes a patch delivery system. Marketed by Guangzhou Sumi Technology Innovation Co., Ltd, this product is identified by NDC 87518-189 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
87518-189-25
Package Description
25 BAG in 1 BOX / 1 PATCH in 1 BAG / 8 g in 1 PATCH
Product Code
87518-189
11-Digit Billing Format
87518018925
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidocaine Knee Pain Relief Patch
Non-Proprietary Name
Lidocaine
Substance Name
Lidocaine
Dosage Form
Patch - A drug delivery system that often contains an adhesive backing that is usually applied to an external site on the body. Its ingredients either passively diffuse from, or are actively transported from, some portion of the patch. Depending upon the patch, the ingredients are either delivered to the outer surface of the body or into the body. A patch is sometimes synonymous with the terms ‘extended release film’ and ‘system’.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
LIDOCAINE .04 g/g
Pharmacologic Class
Usage Information
Adults and Children above 12 years old:· Clean and dry the affected area.· Tear off the protective film and apply the exposed part of the patch to the affected area.· Carefully remove remaining film while pressing the patch firmly on the skin.· Apply 1 patch at a time to affected area, not more than 3 to 4 times daily.· Remove patch from the skin after at most 8-hour applicationChildren under age of 12:Consult a doctor

Regulatory & Marketing

Labeler Name
Guangzhou Sumi Technology Innovation Co., Ltd
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-20-2026
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (87518-189). Click a package code to view its specific billing and regulatory data.

87518-189-15
15 BAG in 1 BOX / 1 PATCH in 1 BAG / 8 g in 1 PATCH
87518-189-35
35 BOX in 1 BOX / 1 PATCH in 1 BOX / 8 g in 1 PATCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 87518-189-25 identifies a specific commercial package of 25 bag in 1 box / 1 patch in 1 bag / 8 g in 1 patch of Lidocaine Knee Pain Relief Patch, a human over the counter drug labeled by Guangzhou Sumi Technology Innovation Co., Ltd. This patch is formulated for topical use and contains lidocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangzhou Sumi Technology Innovation Co., Ltd on April 20, 2026. The current certification is valid through December 31, 2027.

How is this Guangzhou Sumi Technology Innovation Co., Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 87518018925. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
87518-189-25
11-Digit CMS (5-4-2)
87518-0189-25

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.